Any content you receive is for information purposes only. Always conduct your own research.

*Sponsored

Krypton Street Just Announced (CABR) Is Topping Our Watchlist Starting This Morning—Thursday, January 22, 2026.

Don’t Miss The Next Breakout—Get Real-Time Alerts Sent Directly 

To Your Phone. Up To 10X Faster Than Email.

Get (CABR) On Your Screen While It’s Still Early…

January 22, 2026

Morning Focus | (CABR) Just Hit Our Watchlist With 7 Potential Catalysts

Dear Reader,

A new standard is taking hold, and it’s changing what people expect from the products they use every day. Shoppers are reading labels more closely, questioning ingredients, and demanding evidence instead of slogans.

That pressure is reshaping entire categories—fast.

Some brands are scrambling to adjust, while a smaller group is already built for where demand is heading.

The most interesting names aren’t always the loudest—they’re the ones securing real advantages behind the scenes.

One little-known company has made a series of moves that are now drawing a much wider spotlight

Across the global skincare and wellness landscape, consumers are moving away from harsher chemical-based solutions in favor of science-backed, natural alternatives.

Emerging as a name tied to this shift is Caring Brands Inc. (Nasdaq: CABR), a healthcare and consumer products company focused on dermatology and personal care.

And that’s just one of the reasons why (CABR) is topping our watchlist this morning—Thursday, January 22, 2026.

But keep in mind, (CABR) has less than 5M shares listed as available to the public. When companies have small floats like this, the potential exists for big moves if demand begins to change.

Recently, (CABR) made an approximate 130% move from $0.71 on November 18, 2025 to $1.65 on December 8, 2025.

It also saw several double-digit percentage moves, including an approximate 40% overnight move from $0.86 on January 20, 2026 to $1.22 on January 21, 2026, according to Barchart.

Now the setup gets even more interesting—because recent corporate milestones have expanded who can access the name, how closely it’s being watched, and how the story can unfold from here.

Following a recent Nasdaq uplisting and supported by a tightly held share structure, the company is expanding a portfolio built around licensed technologies and condition-specific products.

Pioneering the Future of Therapeutic Skincare

Based in Scottsdale, Arizona, Caring Brands Inc. (Nasdaq: CABR) is a diversified healthcare and consumer products company dedicated to improving lives through advancedbiotechnology and wellness solutions.

The company operates in the high-growth sectors of dermatology and personal care, targeting widespread conditions worldwide such as psoriasis, vitiligo, and eczema.

By leveraging a unique licensing and development model, (CABR) acquires rights to clinically proven technologies, allowing them to bypass traditional R&D hurdles and move straight toward commercialization.

The company’s portfolio is built on a foundation of safety and efficacy. Their flagship offerings include the NoStingzline, which provides protection against jellyfish stings and lice, and a suite of hair loss treatments.

What distinguishes (CABR) from its peers is its commitment to “clean” science—developing products that are as gentle on the body as they are effective against the condition.

This approach has allowed the company to establish a foothold in a competitive market where consumers are increasingly wary of synthetic side effects.

Core Growth Drivers and Market Positioning

The Emesyl Breakthrough In a major operational milestone, (CABR) recently announced it has secured an exclusive global license to manufacture and market Emesyl.

This product represents a potential paradigm shift in the treatment of nausea and motion sickness.

Unlike traditional pills that require digestion and time to take effect, Emesyl is a topical gel that is absorbed through the skin, offering a rapid and non-invasive alternative.

The global market for anti-emetics is substantial, and (CABR)’s unique delivery mechanism could position it to gain share over time.

Strategic Capital and Nasdaq PresenceIn November 2025, (CABR) successfully completed a $4M public offering anduplisted to the Nasdaq Capital Market.

This move is critical for the company’s long-term trajectory, as it provides increased liquidity, transparency, and access to a broader base of institutional and retail participants. The fresh capital is earmarked for expanding marketing efforts, scaling production, and further developing their science-based pipeline.

What’s already clear is that multiple pieces are lining up at once for (CABR)—a Nasdaq presence, fresh capital for scale-up, and a product strategy built around licensed technologies.

Add an exclusive global license for Emesyl and a tightly held share structure, and it’s easy to see why attention has been building.

Put it all together, and (CABR) becomes the kind of name worth understanding before the next wave of updates hits.

7 Reasons Why (CABR) Is Topping Our Watchlist This Morning—Thursday, January 22, 2026…

1. Small Float: With less than 5M shares available to the public, (CABR)’s small float could witness the potential for big moves if demand begins to shift.

2. Recent Momentum: In under a month, (CABR) showcased an approximate 130% move between November and December 2025, followed by multiple double-digit moves including an (approx.) 40% overnight swing in January 2026.

3. Newly Listed on the Nasdaq: A November 2025 uplisting placed (CABR)on the Nasdaq Capital Market, expanding visibility, access, and reporting standards.

4. Exclusive License: Through a newly secured global license, (CABR) controls manufacturing and marketing rights to Emesyl, a topical alternative for nausea and motion sickness.

5. Clean Science: A portfolio centered on safety-focused, non-harsh formulations positions (CABR) alongside shifting consumer preferences toward gentler, science-backed solutions.

6. Targeted Conditions: Operations focused on dermatology and personal care allow (CABR) to address widely prevalent skin conditions such as psoriasis, vitiligo, and eczema.

7. Capital Resources: Completion of a $4M public offering provides (CABR)with funding designated for marketing expansion, production scaling, and continued pipeline development.

Get (CABR) On Your Screen While It’s Still Early…

As we watch the healthcare sector evolve, companies like Caring Brands Inc. (Nasdaq: CABR) that bridge the gap between natural wellness and clinical science are becoming increasingly rare.

The combination of a tiny share float, a fresh Nasdaq listing, and the acquisition of global licenses for innovative delivery systems like Emesyl makes this a company that demands attention.

While the markets can be volatile, the recent momentum in (CABR) suggests the potential for a new wave of interest is forming.

Whether it is the expansion of their hair loss treatments or the global rollout of their new licensing agreements, there are multiple potential catalysts on the horizon that could drive attention.

We have all eyes on (CABR) this morning.

Take a look at (CABR) while it’s still early.

Also, keep a lookout for my next update, it could be here within the next 60-90 minutes.

Sincerely,

Alex Ramsay
Co-Founder / Managing Editor
Krypton Street Newsletter

KryptonStreet.com (“KryptonStreet” or “KS” ) is owned by Media 1717 LLC, a single member limited liability company. Data is provided from third-party sources and KS is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile KS brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.

Pursuant to an agreement between Media 1717 LLC and TD Media LLC, Media 1717 LLC has been hired for a period beginning on 01/21/2026 and ending on 01/22/2026 to publicly disseminate information about (CABR:US) via digital communications. Under this agreement, Media 1717 LLC has been paid eight thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did not receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.

Neither Media 1717 LLC, TD Media LLC and their member own shares of (CABR:US).

Please see important disclosure information here: https://kryptonstreet.com/disclosure/cabr-pvydi/#detailsMedia 1717 LLC6586 W Atlantic AveUnit #2086Delray Beach, FL 33446UnsubscribeUpdate Profile | Constant Contact Data NoticeSent by alex@kryptonstreet.com